Upload
lloydhuni
View
218
Download
0
Embed Size (px)
Citation preview
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 1/21
PID and Its Sequelae
Z Mike Chirenje MD FRCOG
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 2/21
Physiology of Vag Discharge
What controls contents of vaginal
environment in a woman of reproductive
age?
Micro-environment vagina-cervical
compartment is controlled by lactobacillus
species to maintain ph acid <4.5)
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 3/21
Vaginal Discharge and STI
• What is the prevalence of STI(HIV,GC,CT,TV,Syphilis) among womenpresenting with abnormal vaginal
discharge• How much does Candida albicans and BV
contribute to this prevalence in abnormaldischarge?
• Candidiasis and BV are not necessarilySTI but associated with sexual intercourse
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 4/21
Selected Participant Characteristics
in HPTN 035 Study (N=3099)
Percent of Participants with Infection
Diagnosed During Screening
Infection Harare Site (600) All Sites Combined
Bacterial vaginosis byNugent Score (7-10)
27% 36%
Chlamydia 3% 3%
Gonorrhea <1% 1%
Syphilis 2% 2%
Trichomoniasis 4% 7%
Herpes simplex virus-2 34% 46%
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 5/21
Cervicitis
• Anatomically, the cervix has 2 distinct
portions namely ectocervix that merges
into upper vaginal wall and endocervix that
merges into endometrial gland lining
• Cervicitis is inflammation of endocervical
mucosa
• Most commonly caused by an STI
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 6/21
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 7/21
Cervicitis
• Chlamydia trachomatis and N. gonorrhea
cause muco-purelent discharge
• Herpes simples virus and T.vaginalis
cause a ectocervicitis
• ICC,foreign body,trauma,other viral
infections, schistosomiasis are less
frequent causes
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 8/21
Complications of cervical infections
• Cervix is entry to upper genital tract
(normally sterile if there is no anatomic
disruption)
• Can result in ascending infection PID
• Neonatal infection (CT,GC, Herpes)
•
Reinfection of original partner or newpartner
• Disseminated GC
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 9/21
Gonorrhoea in F
• 5-10 days incubation (20-40% sub-clinical)
• Cervicitis,urethritis,pharyngitis,conjuctivitis
and proctitis
• Gonococcal cervicitis is often
asymptomatic
•
Neisseria gonorrhoea is gram negdiplococci under the microscope
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 10/21
Chlamydia
• Typically presents as muco-purelent
discharge, in a cervix that exhibits contact
bleeding and has oedema
• 1-3 weeks incubation, often subclinical
• Is an intracellular bacterium detected by
DNA metods
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 11/21
Gonorrhoea and chlamydia
trachomatis
= colonizes endocervix, urethra, rectum, pharynx.
= should be sampled for culture or DNA probe
testing, PCR, LCR.
= 10 to 20% develop PID if untreated.
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 12/21
PID
• Is an upper genital tract infection
(endometritis,salpingitis,oophoritis and/or
pelvic peritonitis)
• The infection occurs from ascending
genital infection unrelated to child birth or
surgical manipulations
• Clinically divided into sub-clinical, mild
(most cases) severe,
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 13/21
PID
• Complications of untreated PID include:
Pelvic abscess, severe peritonitis
Infertility from blocked fallopian tubesand pelvic adhesions
Chronic pelvic pain and dysparunia
Ectopic pregnancy that can rupture andcause death
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 14/21
Aetiology of PID
• GC and CT are the most commonaetiological agents
• Several other anaerobic bacterial species
found in vagina (bacteriodes,anaerobicGm positive cocci,E.coli, facultative Gmneg rods and Mycoplasma hominis) areusually accompanying pathogens
• Typically a woman with PID has 2 or moreof these pathogens
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 15/21
PID
• Because the infection is often of mixed
pathogens that we may not be able to
detect precise microbiological species, a
broad spectrum of antibiotics iscornerstone to managing these women
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 16/21
Clinical Features of PID
• LAP is common presentation that must be
differentiated from women with ectopic
pregnancy,appendecitis complications of
pregnancy like miscarriage
• Dyspareunia
• Vaginal discharge
• Abnormal Uterine bleeding
• Others (fever,nausea/vomoting)
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 17/21
PID
• Clinical symptoms and signs are variableand therefore a good history and physicalexam are critical in making a correct DX
• LAP, cervical exitation tenderness,adnexae tenderness, rebound tendernessmay be present in a woman with abnormalvaginal discharge
• Adnexae/pelvic mass that is tender maybe a significant finding
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 18/21
PID
• All patients with severe PID must be
hospitalized to allow IV antibiotic therapy
and response to treatment (Temp chart
and clinical response of lower/pelvicexam)
• In general, clinicians would rather over
treat than under treat women suspected tohave PID
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 19/21
PID in HIV positive
• Several studies have found seroprevalence of
HIV in hospitalized PID patients.
• Clinical presentation is observed to be more
severe in HIV positive compared to HIV negative
(Cohen 1998, Kenyan study) particularly withlower wbc count.
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 20/21
• Tubo-ovarian abscess, CMV, TB, TV are
reported in African studies to be more
common in HIV infected women (Margolis
Cape Town 1992, Moodley Durban 2002).
7/28/2019 2-Chirenje Pelvic Inflammatory Disease.pdf
http://slidepdf.com/reader/full/2-chirenje-pelvic-inflammatory-diseasepdf 21/21
• Microbiology of infection and response tostandard AB regimens are similar to HIVuninfected women.
• Aggressive parenteral regimen whenmanaging HIV infected women with PID is
recommended